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Supplementary Table 1: Pearson Correlations of Age, Intelligence and Trait Anxiety with Change 
Scores from Placebo 
 
 Age 16PF STAI 
Gain RF Mean (1mg) 
 
r 0.155 -0.016 -0.156 
p 0.382 0.929 0.379 
    
Gain RN Mean (1mg) r 0.002 -0.146 -0.198 
p 0.990 0.411 0.263 
    
Gain LN Mean (1mg) r -0.019 -0.017 -0.014 
p 0.914 0.926 0.936 
    
Gain LF Mean (1mg) r 0.034 -0.053 -0.027 
p 0.848 0.767 0.879 
    
Gain RF Mean (2mg) r 0.252 0.002 -0.119 
p 0.151 0.990 0.502 
    
Gain RN Mean (2mg) r 0.097 0.160 -0.060 
p 0.584 0.366 0.734 
    
Gain LN Mean (2mg) r 0.222 0.449 -0.155 
p 0.207 0.008 0.381 
    
Gain LF Mean (2mg) r 0.208 0.350 -0.157 
p 0.238 0.042 0.375 
    
Spatial Error RF Mean (1mg) r -0.082 -0.017 0.099 
p 0.644 0.923 0.577 
    
Spatial Error RN Mean (1mg) r -0.048 0.088 0.200 
p 0.788 0.621 0.256 
    
Spatial Error LN Mean (1mg) r 0.045 -0.101 -0.074 
p 0.800 0.571 0.680 
    
Spatial Error LF Mean (1mg) r -0.068 0.030 0.045 
p 0.700 0.865 0.802 
    
Spatial Error RF Mean (2mg) r -0.258 -0.004 0.099 
p 0.140 0.984 0.579 
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Spatial Error RN Mean (2mg) r -0.121 -0.009 0.138 
p 0.496 0.958 0.436 
    
Spatial Error LN Mean (2mg) r -0.207 -0.310 0.097 
p 0.240 0.074 0.584 
    
Spatial Error LF Mean (2mg) r -0.130 -0.107 0.225 
p 0.463 0.547 0.202 
    
Average Velocity RF Mean 
(1mg) 
r 0.139 0.100 -0.079 
p 0.431 0.573 0.656 
    
Average Velocity RN Mean 
(1mg) 
r -0.023 -0.076 -0.063 
p 0.896 0.668 0.723 
    
Average Velocity LN Mean 
(1mg) 
r 0.000 0.114 -0.156 
p 0.998 0.519 0.379 
    
Average Velocity LF Mean (1mg) r 0.074 -0.046 -0.230 
p 0.678 0.797 0.190 
    
Average Velocity RF Mean 
(2mg) 
r 0.252 0.165 0.026 
p 0.150 0.352 0.886 
    
Average Velocity RN Mean 
(2mg) 
r 0.017 0.168 0.000 
p 0.925 0.342 10.000 
    
Average Velocity LN Mean 
(2mg) 
r 0.058 0.463 -0.116 
p 0.745 0.006 0.514 
    
Average Velocity LF Mean (2mg) r 0.199 0.339 -0.176 
p 0.259 0.050 0.319 
    
Peak Velocity RF Mean (1mg) r 0.166 0.053 -0.039 
p 0.349 0.768 0.827 
    
Peak Velocity RN Mean (1mg) r 0.119 -0.127 0.027 
p 0.501 0.475 0.878 
    
Peak Velocity LN Mean (1mg) r 0.091 -0.153 0.034 
p 0.609 0.388 0.850 
    
Peak Velocity LF Mean (1mg) r 0.011 -0.073 -0.018 
p 0.951 0.681 0.918 
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Peak Velocity RF Mean (2mg) r 0.208 -0.016 0.045 
p 0.238 0.930 0.801 
    
Peak Velocity RN Mean (2mg) r 0.183 0.066 0.035 
p 0.300 0.712 0.844 
    
Peak Velocity LN Mean (2mg) r 0.195 0.350 -0.082 
p 0.270 0.043 0.643 
    
Peak Velocity LF Mean (2mg) r 0.215 0.374 -0.081 
p 0.222 0.029 0.648 
    
Duration RF Mean (1mg) r -0.075 -0.093 0.045 
p 0.675 0.602 0.801 
    
Duration RN Mean (1mg) r 0.087 -0.036 -0.247 
p 0.625 0.838 0.158 
    
Duration LN Mean (1mg) r -0.014 -0.129 0.176 
p 0.936 0.466 0.320 
    
Duration LF Mean (1mg) r -0.062 0.031 0.375 
p 0.729 0.860 0.029 
    
Duration RF Mean (2mg) r 0.005 -0.190 -0.106 
p 0.976 0.281 0.552 
    
Duration RN Mean (2mg) r 0.136 0.021 -0.087 
p 0.444 0.904 0.626 
    
Duration LN Mean (2mg) r 0.185 -0.111 0.029 
p 0.294 0.533 0.872 
    
Duration LF Mean (2mg) r 0.065 0.007 0.062 
p 0.716 0.967 0.730 
    
Latency RF Mean (1mg) r 0.050 -0.239 -0.200 
p 0.777 0.174 0.258 
    
Latency RN Mean (1mg) r 0.205 -0.063 -0.266 
p 0.244 0.724 0.128 
    
Latency LN Mean (1mg) r 0.259 0.157 -0.237 
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p 0.140 0.375 0.178 
    
Latency LF Mean (1mg) r 0.283 0.095 -0.293 
p 0.105 0.592 0.093 
    
Latency RF Mean (2mg) r 0.285 -0.038 -0.209 
p 0.103 0.831 0.235 
    
Latency RN Mean (2mg) r 0.210 -0.203 -0.216 
p 0.233 0.249 0.220 
    
Latency LN Mean (2mg) r 0.198 0.186 -0.086 
p 0.261 0.292 0.629 
    
Latency LF Mean (2mg) r 0.170 0.046 -0.140 
p 0.336 0.797 0.430 
    
Gain RF ICV (1mg) r 0.027 -0.199 -0.015 
p 0.881 0.258 0.932 
    
Gain RN ICV (1mg) r -0.051 -0.115 0.085 
p 0.773 0.519 0.632 
     
Gain LN ICV (1mg) r 0.175 -0.035 -0.154 
p 0.322 0.845 0.385 
     
Gain LF ICV (1mg) r -0.042 0.181 -0.110 
p 0.815 0.305 0.537 
     
Gain RF ICV (2mg) r -0.251 -0.159 0.176 
p 0.152 0.368 0.319 
     
Gain RN ICV (2mg) r -0.098 -0.030 0.003 
p 0.580 0.866 0.985 
     
Gain LN ICV (2mg) r -0.248 -0.375 0.275 
 p 0.158 0.029 0.115 
    
Gain LF ICV (2mg) r -0.121 0.107 0.251 
p 0.496 0.549 0.153 
    
Spatial Error RF ICV (1mg) r 0.140 -0.203 -0.194 
p 0.428 0.248 0.271 
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Spatial Error RN ICV (1mg) r -0.040 -0.140 -0.077 
p 0.824 0.429 0.666 
    
Spatial Error LN ICV (1mg) r 0.047 0.116 -0.056 
p 0.794 0.515 0.752 
    
Spatial Error LF ICV (1mg) r 0.002 0.255 -0.310 
p 0.993 0.145 0.075 
    
Spatial Error RF ICV (2mg) r 0.092 -0.171 0.017 
p 0.605 0.332 0.922 
    
Spatial Error RN ICV (2mg) r -0.004 -0.049 -0.193 
p 0.982 0.782 0.274 
    
Spatial Error LN ICV (2mg) r -0.183 -0.094 0.258 
p 0.300 0.595 0.140 
    
Spatial Error LF ICV (2mg) r -0.062 0.274 0.110 
p 0.729 0.117 0.536 
    
Average Velocity RF ICV (1mg) r -0.037 -0.161 0.055 
p 0.835 0.362 0.756 
    
Average Velocity RN ICV (1mg) r 0.075 -0.091 0.071 
p 0.675 0.610 0.690 
    
Average Velocity LN ICV (1mg) r 0.281 -0.079 -0.002 
p 0.108 0.656 0.993 
    
Average Velocity LF ICV (1mg) r -0.083 0.189 0.128 
p 0.640 0.284 0.469 
    
Average Velocity RF ICV (2mg) r -0.301 -0.247 0.234 
p 0.084 0.159 0.182 
    
Average Velocity RN ICV (2mg) r 0.067 -0.046 -0.046 
p 0.705 0.797 0.797 
    
Average Velocity LN ICV (2mg) r -0.116 -0.375 0.317 
p 0.515 0.029 0.068 
    
Average Velocity LF ICV (2mg) r -0.046 0.089 0.198 
p 0.795 0.618 0.262 
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Peak Velocity RF ICV (1mg) r 0.004 -0.061 -0.007 
p 0.981 0.733 0.968 
    
Peak Velocity RN ICV (1mg) r 0.064 0.083 -0.013 
p 0.719 0.641 0.943 
    
Peak Velocity LN ICV (1mg) r 0.190 0.145 -0.037 
p 0.282 0.415 0.837 
    
Peak Velocity LF ICV (1mg) r -0.052 0.116 0.110 
p 0.769 0.514 0.535 
    
Peak Velocity RF ICV (2mg) r -0.018 -0.119 -0.008 
p 0.919 0.502 0.963 
    
Peak Velocity RN ICV (2mg) r -0.010 0.120 -0.009 
p 0.955 0.500 0.960 
    
Peak Velocity LN ICV (2mg) r -0.098 -0.245 0.262 
p 0.582 0.163 0.134 
    
Peak Velocity LF ICV (2mg) r -0.168 0.102 0.082 
p 0.342 0.567 0.645 
    
Duration RF ICV (1mg) r -0.050 -0.081 0.155 
p 0.780 0.648 0.382 
    
Duration RN ICV (1mg) r 0.069 0.012 -0.023 
p 0.697 0.947 0.896 
    
Duration LN ICV (1mg) r 0.226 0.090 -0.068 
p 0.198 0.614 0.704 
    
Duration LF ICV (1mg) r -0.140 0.138 0.224 
p 0.429 0.436 0.203 
    
Duration RF ICV (2mg) r -0.055 0.015 0.272 
p 0.757 0.931 0.119 
    
Duration RN ICV (2mg) r 0.216 -0.025 -0.189 
p 0.220 0.887 0.284 
    
Duration LN ICV (2mg) r -0.038 -0.327 0.179 
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p 0.832 0.059 0.312 
    
Duration LF ICV (2mg) r 0.129 0.043 0.037 
p 0.466 0.809 0.833 
    
Latency RF ICV (1mg) r -0.073 -0.313 -0.096 
p 0.684 0.071 0.587 
    
Latency RN ICV (1mg) r 0.102 0.244 -0.205 
p 0.568 0.165 0.244 
    
Latency LN ICV (1mg) r 0.198 -0.018 -0.240 
p 0.262 0.919 0.172 
    
Latency LF ICV (1mg) r 0.156 0.233 -0.259 
p 0.377 0.184 0.139 
    
Latency RF ICV (2mg) r 0.084 -0.039 -0.143 
p 0.638 0.825 0.419 
    
Latency RN ICV (2mg) r 0.067 0.023 -0.463 
p 0.707 0.896 0.006 
    
Latency LN ICV (2mg) r 0.074 -0.068 -0.158 
p 0.677 0.703 0.371 
    
Latency LF ICV (2mg) r -0.302 -0.085 0.085 
p 0.083 0.631 0.631 
    
Q RF (2mg) r 0.107 -0.119 0.010 
p 0.548 0.504 0.954 
    
Q RN (2mg) r 0.203 -0.048 0.035 
p 0.248 0.786 0.845 
    
Q LN (2mg) r 0.168 -0.108 0.009 
p 0.342 0.543 0.958 
    
Q LF (2mg) r 0.067 0.152 0.113 
p 0.705 0.392 0.525 
    
Skewness RF (2mg) r -0.146 -0.105 0.089 
p 0.410 0.556 0.615 
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Skewness RN (2mg) r -0.279 0.051 0.271 
p 0.110 0.774 0.121 
    
Skewness LN (2mg) r -0.026 0.243 0.021 
p 0.883 0.166 0.904 
    
Skewness LF (2mg) r -0.154 0.063 0.437 
p 0.385 0.725 0.010 
    
Q RF (1mg) r 0.104 -0.003 -0.016 
p 0.559 0.988 0.927 
    
Q RN (1mg) r 0.123 -0.065 0.032 
p 0.489 0.713 0.857 
    
Q LN (1mg) r 0.060 -0.263 0.139 
p 0.734 0.132 0.434 
    
Q LF (1mg) r -0.080 -0.007 0.260 
p 0.652 0.971 0.137 
    
Skewness RF (1mg) r 0.036 -0.046 0.125 
p 0.841 0.796 0.482 
    
Skewness RN (1mg) r -0.050 -0.009 0.009 
p 0.781 0.961 0.961 
    
Skewness LN (1mg) r 0.207 0.175 -0.222 
p 0.240 0.322 0.207 
    
Skewness LF (1mg) r -0.068 0.358 0.128 
p 0.703 0.038 0.471 
    
Curvature RF Mean (1mg) r -0.015 0.008 0.071 
p 0.933 0.966 0.691 
    
Curvature RN Mean (1mg) r 0.063 -0.127 0.003 
p 0.725 0.475 0.988 
    
Curvature LN Mean (1mg) r -0.048 0.179 0.147 
p 0.790 0.312 0.406 
    
Curvature LF Mean (1mg) r 0.226 0.126 0.114 
p 0.198 0.479 0.519 
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Curvature RF ICV (1mg) r 0.146 -0.123 -0.397 
p 0.411 0.489 0.020 
    
Curvature RN ICV (1mg) r -0.105 -0.376 0.065 
p 0.556 0.028 0.714 
    
Curvature LN ICV (1mg) r 0.138 -0.067 0.264 
p 0.436 0.706 0.131 
    
Curvature LF ICV (1mg) r 0.016 0.161 -0.061 
p 0.928 0.363 0.734 
    
Curvature RF Mean (2mg) r 0.113 0.096 0.064 
p 0.524 0.590 0.720 
    
Curvature RN Mean (2mg) r 0.281 -0.050 -0.133 
p 0.108 0.778 0.453 
    
Curvature LN Mean (2mg) r 0.081 0.097 0.168 
p 0.649 0.583 0.343 
    
Curvature LF Mean (2mg) r 0.047 0.037 0.119 
p 0.792 0.835 0.502 
    
Curvature RF ICV (2mg) r -0.080 -0.024 -0.272 
p 0.653 0.893 0.120 
    
Curvature RN ICV (2mg) r -0.223 -0.480 -0.045 
p 0.206 0.004 0.801 
    
Curvature LN ICV (2mg) r -0.120 -0.179 0.415 
p 0.497 0.312 0.015 
    
Curvature LF ICV (2mg) r -0.202 -0.200 0.139 
p 0.253 0.256 0.432 
 
Legend: Saccadic variables indicate change scores from placebo. 16PF is the 16PF reasoning ability 
scale (Cattell et al., 1970). STAI is the State Trait Anxiety Inventory (Spielberger et al., 1983). N=34. 
RF=right far, RN=right near, LN=left near, LF=left far. Further details on saccadic variables are found 
in the main manuscript. 
 
